Completed NA INTERVENTIONAL 2-arm NCT02668276

Engaging Newly Diagnosed Men About Cancer Treatment Options (ENACT)

The Impact of a Gene Expression Profile on Treatment Choice and Outcome Among Minority Men Newly Diagnosed With Prostate Cancer: A Randomized Trial

Sponsor: Cook County Hospital

Conditions Prostatic Neoplasms

Interventions Standard NCCN counseling Standard NCCN counseling and Oncotype DX results

Updated 7 times since 2017 Last updated: Oct 1, 2020 Started: Apr 30, 2016 Primary completion: Aug 31, 2019 Completion: Aug 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Prostatic Neoplasms, this trial is completed. The trial is conducted by Cook County Hospital and has accumulated 7 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Oct 2019 — Nov 2020 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Jun 2018 — Oct 2019 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cook County Hospital
Genomic Health®, Inc.
United States Department of Defense
University of Illinois at Chicago

Data source: University of Illinois at Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States